{"id":"W4380084535","doi":"10.1002/hon.3163_109","title":"FAVEZELIMAB PLUS PEMBROLIZUMAB IN ANTI–PD‐1–REFRACTORY CLASSICAL HODGKIN LYMPHOMA (CHL): ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Refractory (planetary science); Medicine; Internal medicine; Oncology; Clinical trial; Gastroenterology; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008677872,0.0003185747,0.001275301,0.0002609687,0.0001444829,0.00001285677,0.0003119222,0.0005996311,0.0002535199],"category_scores_gemma":[0.00124288,0.0001974746,0.0003738475,0.001083813,0.0009153944,0.00008665017,0.0002051427,0.0005713583,0.0001520015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005936667,"about_ca_system_score_gemma":0.0005866663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000705057,"about_ca_topic_score_gemma":0.00002993345,"domain_scores_codex":[0.996842,0.0004736309,0.001047466,0.0005488593,0.0004137355,0.0006742585],"domain_scores_gemma":[0.9959811,0.002921375,0.0004031495,0.0004690308,0.00009980051,0.0001255487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1045041,0.01547001,0.07448643,0.001875316,0.002694874,0.01511171,0.01736836,0.0009551945,0.07371121,0.04409684,0.02768452,0.6220415],"study_design_scores_gemma":[0.05582491,0.00647581,0.8685041,0.0007610132,0.0003197782,0.003156145,0.001670884,0.02436448,0.002885629,0.00286265,0.03239366,0.0007809465],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847438,0.0007526767,0.0003457168,0.006298843,0.0004415524,0.0008263071,0.00001067011,0.0001990017,0.006381421],"genre_scores_gemma":[0.9968187,0.0002153648,0.001628497,0.0008040383,0.0001198433,0.0000986571,0.00003459325,0.00003258492,0.0002477861],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7940177,"threshold_uncertainty_score":0.8052781,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04668407612535397,"score_gpt":0.349987444580797,"score_spread":0.303303368455443,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}